MDB Capital Holdings, LLC (MDBH)
NASDAQ: MDBH · Real-Time Price · USD
6.30
-0.15 (-2.33%)
Apr 1, 2025, 4:00 PM EDT - Market closed
MDB Capital Holdings, LLC Revenue
In the year 2024, MDB Capital Holdings, LLC had annual revenue of $2.09M, down -65.21%. MDB Capital Holdings, LLC had revenue of $1.07M in the quarter ending December 31, 2024, with 15.99% growth.
Revenue (ttm)
$2.09M
Revenue Growth
-65.21%
P/S Ratio
28.47
Revenue / Employee
$52,141
Employees
40
Market Cap
62.69M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.09M | -3.91M | -65.21% |
| Dec 31, 2023 | 6.00M | 4.78M | 391.81% |
| Dec 31, 2022 | 1.22M | 11.05M | -112.40% |
| Dec 31, 2021 | -9.83M | -13.29M | -384.85% |
| Dec 31, 2020 | 3.45M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Berkshire Hathaway | 371.43B |
| JPMorgan Chase & Co. | 166.78B |
| Bank of America | 96.07B |
| Wells Fargo & Company | 77.96B |
| Morgan Stanley | 61.50B |
| HSBC Holdings | 61.25B |
| American Express Company | 60.76B |
| The Goldman Sachs Group | 52.16B |
MDBH News
- 16 hours ago - New PatentVest Pulse Report Maps the Competitive and IP Landscape of the $400B Brain-Computer Interface (BCI) Market - GlobeNewsWire
- 8 days ago - MDB Capital Holdings to Host Fourth Quarter and Full Year 2024 Results Conference Call on Monday March 31, 2025, at 4:30 p.m. Eastern Time - GlobeNewsWire
- 27 days ago - New PatentVest Pulse Report Reveals Transformative Trends in the AI Data Center Patent Race - GlobeNewsWire
- 5 weeks ago - eXoZymes Announces Nasdaq Bell Ringing to Commemorate Initial Public Offering - GlobeNewsWire
- 6 weeks ago - Rebranding Invizyne to eXoZymes Signifies a Sustainable Paradigm Shift in Chemical Production Leveraging AI-Engineered Enzymes - GlobeNewsWire
- 7 weeks ago - Invizyne Technologies Announces Name Change to eXoZymes, Inc. and New Ticker Symbol - GlobeNewsWire
- 3 months ago - Rethinking Diabetes Care: PatentVest Pulse Unveils Key Insights on the Expanding CGM Market and the Innovations Driving Change - GlobeNewsWire
- 4 months ago - MDB Capital Holdings Provides Third Quarter 2024 Update - GlobeNewsWire